Sie sind hier: Startseite > News > FRAUNHOFER IZI, LEIPZIG: INNOVATIVE THERAPY METHOD FOR THE TREATMENT OF BRAIN TUMORS

NEWS.

 

FRAUNHOFER IZI, LEIPZIG: INNOVATIVE THERAPY METHOD FOR THE TREATMENT OF BRAIN TUMORS

FRAUNHOFER IZI, LEIPZIG: INNOVATIVE THERAPY METHOD FOR THE TREATMENT OF BRAIN TUMORS

The Fraunhofer Institute for Cell Therapy and Immunology IZI and the American company Northwest Biotherapeutics Inc. are cooperating in the development of production processes and establishment of an innovative therapy method for the treatment of glioblastomas (brain tumors) in Europe.
Northwest Biotherapeutics has developed an autologous (the body's own) “DCVax®” immunotherapy for various types of cancer. In the USA, the company is already conducting clinical trials for the treatment of glioblastomas and other types of cancer. Such immunotherapies for cancer are beginning to succeed after many decades of research and development. DCVax® is one of the leading technologies at the forefront of this new approach to cancer treatment.
In order to make this DCVax® therapy also available to patients in Europe, the company has now entered cooperation with the Fraunhofer IZI. The initial phase of this cooperation comprises adapting the production processes to European regulations and standards, implementing them in the Fraunhofer IZI's facilities and comprehensive quality management system and obtaining the required official authorizations. Later on, the clinical trial products are supposed to be provided by the Fraunhofer IZI.

More… (pdf)

Source: press release of the Fraunhofer Institute for Cell Therapy and Immunology IZI from 5/23/11.
 

Artikelaktionen